Maureen Andrew
#162,816
Most Influential Person Now
Maureen Andrew's AcademicInfluence.com Rankings
Maureen Andrewphilosophy Degrees
Philosophy
#9450
World Rank
#13011
Historical Rank
Logic
#6425
World Rank
#7942
Historical Rank
Maureen Andrewbiology Degrees
Biology
#13007
World Rank
#16522
Historical Rank
Biochemistry
#2246
World Rank
#2392
Historical Rank
Download Badge
Philosophy Biology
Maureen Andrew's Degrees
- PhD Biochemistry University of California, San Francisco
- Doctorate Medicine Stanford University
Why Is Maureen Andrew Influential?
(Suggest an Edit or Addition)Maureen Andrew's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Development of the human coagulation system in the full-term infant. (1987) (1043)
- Cerebral sinovenous thrombosis in children. (2001) (1004)
- Maturation of the hemostatic system during childhood. (1992) (824)
- Development of the human coagulation system in the healthy premature infant. (1988) (634)
- Neonatal thrombosis: report of a prospective Canadian and international registry. (1995) (540)
- A randomized controlled trial of a low-molecular-weight heparin (enoxaparin) to prevent deep-vein thrombosis in patients undergoing elective hip surgery. (1986) (537)
- Venous thromboembolic complications (VTE) in children: first analyses of the Canadian Registry of VTE. (1994) (520)
- Venous thromboembolic complications (VTE) in children: first analyses of the Canadian Registry of VTE (1994) (497)
- Outcome of Pediatric Thromboembolic Disease: A Report from the Canadian Childhood Thrombophilia Registry (2000) (477)
- Central venous catheter related thrombosis in children: analysis of the Canadian Registry of Venous Thromboembolic Complications. (1998) (390)
- Antithrombotic therapy in children. (1995) (344)
- Randomised trial of intravenous immunoglobulin G, intravenous anti-D, and oral prednisone in childhood acute immune thrombocytopenic purpura (1994) (307)
- Benefit of heparin in central venous and pulmonary artery catheters: a meta-analysis of randomized controlled trials. (1998) (303)
- Frequency and mechanism of neonatal thrombocytopenia. (1986) (294)
- Analysis of warfarin therapy in pediatric patients: A prospective cohort study of 319 patients. (1999) (280)
- Prothrombotic disorders in infants and children with cerebral thromboembolism. (1998) (252)
- The use of low molecular weight heparin in pediatric patients: a prospective cohort study. (2000) (251)
- Low-molecular-weight heparin in pediatric patients with thrombotic disease: a dose finding study. (1996) (240)
- Antithrombotic therapy in children. (2001) (235)
- Venous thromboembolic complications in children. (1993) (229)
- Developmental Hemostasis: Relevance to Thromboembolic Complications in Pediatric Patients (1995) (223)
- A prospective, randomized trial of high-dose intravenous immune globulin G therapy, oral prednisone therapy, and no therapy in childhood acute immune thrombocytopenic purpura. (1993) (220)
- Central venous line-related thrombosis in children: association with central venous line location and insertion technique. (2003) (217)
- DOUBLE-BLIND RANDOMISED TRIAL OF ORG 10172 LOW-MOLECULAR-WEIGHT HEPARINOID IN PREVENTION OF DEEP-VEIN THROMBOSIS IN THROMBOTIC STROKE (1987) (210)
- A randomized, controlled trial of platelet transfusions in thrombocytopenic premature infants. (1993) (208)
- An open-label randomized controlled trial of low molecular weight heparin for the prevention of central venous line-related thrombotic complications in children: the PROTEKT trial. (2003) (206)
- A multicenter, randomized trial comparing heparin/warfarin and acetylsalicylic acid as primary thromboprophylaxis for 2 years after the Fontan procedure in children. (2011) (199)
- Heparin Therapy in Pediatric Patients: A Prospective Cohort Study (1994) (198)
- Increased endogenous thrombin generation in children with acute lymphoblastic leukemia: risk of thrombotic complications in L'Asparaginase-induced antithrombin III deficiency. (1994) (195)
- Heparin‐induced thrombocytopenia and thrombosis: clinical and laboratory studies (1993) (189)
- Safety and outcomes of thrombolysis with tissue plasminogen activator for treatment of intravascular thrombosis in children. (2001) (184)
- Comparison of Venography and Ultrasound for the Diagnosis of Asymptomatic Deep Vein Thrombosis in the Upper Body in Children (2002) (184)
- Benefit of heparin in peripheral venous and arterial catheters: systematic review and meta-analysis of randomised controlled trials (1998) (180)
- Clinical impact of neonatal thrombocytopenia. (1987) (173)
- A histomorphometric comparison of the effects of heparin and low-molecular-weight heparin on cancellous bone in rats. (1997) (173)
- An open-label randomized controlled trial of low molecular weight heparin compared to heparin and coumadin for the treatment of venous thromboembolic events in children: the REVIVE trial. (2003) (172)
- A cross-sectional study evaluating post-thrombotic syndrome in children. (2003) (169)
- Anticoagulation therapy in pediatric patients with sinovenous thrombosis: a cohort study. (1998) (161)
- Oral Anticoagulation Therapy in Pediatric Patients: a Prospective Study (1994) (155)
- A cross-sectional study of catheter-related thrombosis in children receiving total parenteral nutrition at home. (1995) (153)
- Histomorphometric analysis of the effects of standard heparin on trabecular bone in vivo. (1996) (144)
- Trend to efficacy and safety using antithrombin concentrate in prevention of thrombosis in children receiving l-asparaginase for acute lymphoblastic leukemia (2003) (135)
- The use of D-dimer testing and impedance plethysmographic examination in patients with clinical indications of deep vein thrombosis. (1997) (132)
- Factors associated with thrombotic complications after the Fontan procedure: a secondary analysis of a multicenter, randomized trial of primary thromboprophylaxis for 2 years after the Fontan procedure. (2013) (125)
- Guidelines for antithrombotic therapy in pediatric patients. (1998) (124)
- The Relationship of Antiphospholipid Antibodies to Thromboembolic Disease in Systemic Lupus Erythematosus: A Cross-Sectional Study (1991) (119)
- Thrombin Regulation in Children Differs from Adults in the Absence and Presence of Heparin (1994) (113)
- Thromboembolic Complications During Infancy and Childhood (2000) (107)
- Abnormal endothelial factor VIII associated with pulmonary hypertension and congenital heart defects. (1987) (106)
- Fibrin Clot Lysis by Thrombolytic Agents Is Impaired in Newborns due to a Low Plasminogen Concentration (1992) (103)
- Thromboembolic disease and antithrombotic therapy in newborns. (2001) (100)
- Increases in factor VIII complex and fibrinolytic activity are dependent on exercise intensity. (1986) (98)
- The Relationship of Antiphospholipid Antibodies to Thromboembolic Events in Pediatric Patients with Systemic Lupus Erythematosus: A Cross-Sectional Study (1998) (96)
- Home monitoring of warfarin therapy in children with a whole blood prothrombin time monitor. (1995) (94)
- The relevance of developmental hemostasis to hemorrhagic disorders of newborns. (1997) (93)
- A prospective study investigating the mechanism of thrombocytopenia in preeclampsia. (1987) (88)
- Relationship of antiphospholipid antibodies to pregnancy loss in patients with systemic lupus erythematosus: a cross-sectional study. (1992) (88)
- Capillary Whole Blood Monitoring of Oral Anticoagulants in Children in Outpatient Clinics and the Home Setting (2000) (84)
- Heparin therapy in pediatric patients. (1997) (84)
- Developmental hemostasis: relevance to hemostatic problems during childhood. (1995) (84)
- Acquired activated protein C resistance is associated with lupus anticoagulants and thrombotic events in pediatric patients with systemic lupus erythematosus. (2001) (82)
- Hemostasis in childhood acute lymphoblastic leukemia: coagulopathy induced by disease and treatment. (1995) (82)
- Anticoagulant Effects of Heparin in Neonatal Plasma' (1989) (80)
- Thrombolytic Therapy in Pediatric Patients: A Comprehensive Review of the Literature (1996) (78)
- A multicenter study of the treatment of childhood chronic idiopathic thrombocytopenic purpura with anti-D. (1992) (78)
- Blood-compatible biomaterials by surface coating with a novel antithrombin-heparin covalent complex. (2002) (74)
- Alpha-2-macroglobulin may provide protection from thromboembolic events in antithrombin III-deficient children. (1991) (70)
- Cerebral vein thrombosis in childhood systemic lupus erythematosus. (1995) (69)
- Abnormalities in von Willebrand factor and antithrombin III after cardiopulmonary bypass operations for congenital heart disease. (1992) (68)
- An anticoagulant dermatan sulfate proteoglycan circulates in the pregnant woman and her fetus. (1992) (68)
- Effective treatment of ligneous conjunctivitis with topical plasminogen. (2002) (67)
- Heparin sensitivity and resistance in the neonate: an explanation. (1991) (65)
- Enhanced Thrombin Regulation during Warfarin Therapy in Children Compared to Adults (1998) (63)
- Neonatal thrombocytopenia in the hypertensive disorders of pregnancy (1990) (59)
- An Antithrombin III Assay Based on Factor Xa Inhibition Provides a More Reliable Test to Identify Congenital Antithrombin III Deficiency Than an Assay Based on Thrombin Inhibition (1993) (58)
- Homozygous Protein C Deficiency: Description of a New Mutation and Successful Treatment with Low Molecular Weight Heparin (1998) (58)
- Arterial Thromboembolic Complications in Paediatric Patients (1997) (57)
- Heparin clearance and ex vivo recovery in newborn piglets and adult pigs. (1988) (56)
- Acquired antithrombin III deficiency secondary to asparaginase therapy in childhood acute lymphoblastic leukaemia (1994) (55)
- Thrombin regulation in mother and fetus during pregnancy. (1992) (53)
- A placebo-controlled randomized trial of antithrombin therapy in neonatal respiratory distress syndrome. (1998) (52)
- The use of alteplase to restore patency of central venous lines in pediatric patients: a cohort study. (2001) (51)
- Low molecular weight heparin in children (2002) (51)
- Chelation therapy in beta-thalassemia major. III. The role of splenectomy in achieving iron balance. (1981) (49)
- Anticoagulant dermatan sulfate proteoglycan (decorin) in the term human placenta. (1998) (47)
- α2-Macroglobulin Remains as Important as Antithrombin III for Thrombin Regulation in Cord Plasma in the Presence of Endothelial Cell Surfaces (1995) (47)
- Decreased Concentrations of Heparinoids Are Required to Inhibit Thrombin Generation in Plasma from Newborns and Children Compared to Plasma from Adults due to Reduced Thrombin Potential (2002) (47)
- Neonatal thrombotic disease: prevention, diagnosis, and treatment. (1988) (47)
- Thrombin Inhibition Is Impaired in Plasma of Sick Neonates (1992) (47)
- Inhibition of Thrombin by Antithrombin III and Heparin Cofactor II In Vivo (1995) (46)
- Dose-finding and pharmacokinetic profiles of prophylactic doses of a low molecular weight heparin (reviparin-sodium) in pediatric patients. (2003) (46)
- Diagnosis and Treatment of Venous Thromboembolism in Children and Adolescents (1995) (44)
- High-dose intravenous gammaglobulin therapy for neonatal autoimmune thrombocytopenia. (1988) (44)
- Heparin Therapy during Cardiopulmonary Bypass in Children Requires Ongoing Quality Control (1993) (42)
- The influence of developmental haemostasis on the laboratory diagnosis and management of haemostatic disorders during infancy and childhood. (1999) (40)
- Report of Scientific and Standardization Subcommittee on Neonatal Hemostasis Diagnosis and Treatment of Neonatal Thrombosis (1992) (40)
- Hemostatic complications in renal disorders of the young (1996) (40)
- Vitamin K deficiency bleeding (VKDB) in infancy. ISTH Pediatric/Perinatal Subcommittee. International Society on Thrombosis and Haemostasis. (1999) (40)
- Antithrombotic therapy in children. (1999) (39)
- A Randomized Controlled Trial of Low-Molecular-Weight Heparin (Enoxaparin) to Prevent Deep-Vein Thrombosis in Patients Undergoing Elective Hip Surgery (1987) (39)
- Operation Everest II: coagulation system during prolonged decompression to 282 Torr. (1987) (38)
- A comparative study of heel-stick devices for infant blood collection. (1993) (38)
- Venous thromboembolic events in pediatric patients. Diagnosis and management. (1998) (38)
- The comparison of the pharmacokinetics of a low molecular weight heparin in the newborn and adult pig. (1989) (37)
- Factors XI and XII and prekallikrein in sick and healthy premature infants. (1981) (37)
- Failure of thrombolytic therapy in four children with extensive thromboses. (1992) (35)
- Standard assays underestimate the concentration of heparin in neonatal plasma. (1988) (35)
- Antithrombotic Properties of Heparin in a Neonatal Piglet Model of Thrombin-Induced Thrombosis (1988) (34)
- A novel antithrombin-heparin covalent complex: antithrombotic and bleeding studies in rabbits. (1998) (32)
- Hypoxia alters blood coagulation during acute decompression in humans. (1984) (32)
- Age‐related changes in factor VII proteolysis in vivo (1996) (32)
- Placental transport of low molecular weight heparin in the pregnant sheep (1985) (32)
- 111In-oxine platelet survivals in thrombocytopenic infants. (1987) (30)
- Decreased Thrombin Activity of Fibrin Clots Prepared in Cord Plasma Compared with Adult Plasma (1996) (29)
- A549 lung epithelial cells synthesize anticoagulant molecules on the cell surface and matrix and in conditioned media. (1991) (28)
- Do Coagulation Screening Tests Detect Increased Generation of Thrombin and Plasmin in Sick Newborn Infants? (1993) (27)
- Antithrombotic therapy in children. (1995) (27)
- Use of heparin in newborn infants. (1988) (26)
- Dysfunctional Antithrombin III in Sick Premature Infants (1985) (26)
- The prevention and treatment of thromboembolic disease in children: a need for Thrombophilia Programs. (1997) (25)
- Anticoagulation and thrombolysis in children. (1992) (24)
- Influence of exogenous factor VIIa on thrombin generation in cord plasma of full-term and pre-term newborns (2000) (24)
- Plasma Protease Inhibitors in Premature Infants: Influence of Gestational Age, Postnatal Age, and Health Status 1 (1983) (23)
- Effect of heparin loading during congenital heart operation on thrombin generation and blood loss. (1997) (22)
- A Low Molecular Weight Heparin Alters the Fetal Coagulation System in the Pregnant Sheep (1986) (22)
- Fibrinolytic response to venous occlusion is decreased in patients after Kawasaki disease (2003) (22)
- Whole blood heparin concentrations do not correlate with plasma antifactor Xa heparin concentrations in pediatric patients undergoing cardiopulmonary bypass (2000) (22)
- Fibrinolytic System in Adolescents: Response to Venous Occlusion Stress Tests (2003) (21)
- Morphological and Biochemical Features Affecting the Antithrombotic Properties of the Aorta in Adult Rabbits and Rabbit Pups (1998) (20)
- Fibrinogen Has a Rapid Turnover in the Healthy Newborn Lamb (1988) (20)
- Indications and drugs for anticoagulation therapy in children. (1996) (20)
- Central venous catheters for out-patient management of malignant disorders. (1983) (19)
- Thrombin regulation in congenital heart disease after cardiopulmonary bypass operations. (1994) (19)
- Morphologic and Biochemical Features Affecting the Antithrombotic Properties of the Inferior Vena Cava of Rabbit Pups and Adult Rabbits (1998) (18)
- The use of indium-111 oxine platelet scintigraphy and survival studies in pediatric patients with thrombocytopenia. (1989) (17)
- A new short infusion dosage regimen of recombinant tissue plasminogen activator in patients with venous thromboembolic disease. (1990) (17)
- Coagulation abnormalities in chronic peritoneal dialysis (1990) (16)
- Blood component therapy in neonatal hemostatic disorders. (1995) (15)
- Plasma dermatan sulfate proteoglycan in a patient on chronic hemodialysis. (1993) (13)
- Spontaneous arterial thrombosis in children. (1999) (13)
- Effect of covalent serpin-heparinoid complexes on plasma thrombin generation on fetal distal lung epithelium. (2003) (13)
- Fibrin clot lysis by tissue plasminogen activator (tPA) is impaired in plasma from pediatric patients undergoing orthotopic liver transplantation. (1995) (12)
- Fetal lamb coagulation system during normal birth (1988) (11)
- Polypeptide-polysaccharide conjugates produced by spontaneous non-enzymatic glycation. (1998) (11)
- A simple screening test for evaluating prolonged partial thromboplastin times in newborn infants. (1982) (11)
- Covalent Heparin Cofactor II-Heparin and Heparin Cofactor II-Dermatan Sulfate Complexes (1998) (10)
- Influence of activated factor VII concentrates on thrombin generation in full‐term and preterm neonates (2000) (9)
- Impaired Fibrinolytic Activity Is Present in Children with Dyslipidemias (2004) (9)
- Influence of fetal pulmonary epithelium on thrombin activity. (1991) (8)
- Effect of a novel covalent antithrombin-heparin complex on thrombin generation on fetal distal lung epithelium. (1998) (8)
- Demonstration of kallikrein-like protease activity in nonactivated plasma of patients with Cooley's anemia. (1983) (7)
- Neonatal autoimmune thrombocytopenia: role of high-dose intravenous immunoglobulin G therapy (1989) (7)
- Influence of mechanical stretch on thrombin regulation by fetal mixed lung cells. (1998) (7)
- Neonatal thrombocytopenia. (1984) (6)
- Thrombin inhibition by fetal distal lung epithelium is different in fetal and adult plasma. (1994) (6)
- Cardiopulmonary bypass in the neonate. (1993) (6)
- Fetal lamb coagulation system during birth asphyxia (1988) (5)
- Assessment of coagulation cascade during air microembolization of the lung. (1983) (5)
- Standardization of prothrombin times in newborn infants. (1993) (5)
- Coagulation screening tests in high risk neonates: a prospective cohort study. (1992) (5)
- Hypoxia-induced vasopressin release and coagulopathy in a normal subject. (1985) (5)
- Abstract 1157: A Multicentre Randomized Trial Comparing Heparin/warfarin Versus Aspirin As Primary Thromboprophylaxis For Two Years After Fontan Procedure In Children (2008) (5)
- Developmental changes in red cell creatine and free erythrocyte protoporphyrin in healthy full-term infants during the first 6 months of life. (1986) (4)
- Neonatal Hematology: Hemostatic abnormalities (2005) (4)
- Fluosol-DA causes pulmonary hypertension and increased lung lymph flow in unanesthetized sheep. (1985) (4)
- Society for Pediatric Research Presidential Address 1998: The SPR and 1-800-NO-CLOTS: A Common Vision* (1998) (3)
- Stability and sterility of recombinant tissue plasminogen activator at -30 degrees C. (2000) (3)
- THE RELATIONSHIP OF ANTIPHOSPHOLIPID ANTIBODIES TO THROMBOEMBOLIC DISEASE IN SYSTEMIC LUPUS ERYTHEMATOSUS IN CHILDREN: A CROSS-SECTIONAL STUDY.▴ 899 (1996) (3)
- Neonatal Thrombosis: A Critical Appraisal of the Available Evidence on Prevention, Diagnosis, and Treatment (1991) (3)
- Anticoagulant and Thrombolytic Therapy in the Newborn (1991) (3)
- a-2-Macroglobulin May Provide Protection From Thromboembolic Events in Antithrombin 111-Deficient Children (2003) (2)
- RIGHT ATRIAL THROMBOSIS IN PEDIATRIC PATIENTS: ANALYSIS OF THE CANADIAN REGISTRY OF VENOUS THROMBOEMBOLIC COMPLICATIONS. ▴ 907 (1996) (2)
- Noninvasive diagnosis of pulmonary hemorrhage in rheumatoid arthritis. (1983) (2)
- The Use of Low Molecular Weight Heparin in Pediatric Patients: Review of A Single Institution Experience • 761 (1998) (2)
- Effect of a novel covalent antithrombin-heparin complex on thrombin generation on fetal distal lung epithelium. (1998) (2)
- Unactivated Plasma Of Children With Cooley’s Anemia Has Serine Protease Activity (1981) (1)
- Developmental changes in red cell creatine and free erythrocyte protoporphyrin in healthy premature infants during the first six months of life. (1987) (1)
- Rabbit Platelets do not Express Fc Receptors for IgG. (1992) (1)
- Anticoagulation monitoring: Accurate results with patient self-testing in a multicenter trial (1996) (1)
- Thromboembolic Disease in Children: A New Epidemic in Tertiary Care Pediatrics (1999) (1)
- α2-MACROGLOBULIN AND ANTITHROMBIN III ARE EQUALLY IMPORTANT INHIBITORS OF THROMBIN IN NEONATAL PLASMA (1987) (1)
- EVALUATION OF AN AUTOMATED COAGULATION ANALYZER (1987) (1)
- neonates : a prospective cohort study . Coagulation screening tests in high risk (2006) (1)
- #406 Central venous catheter related thrombosis (CVLT) in children: analysis of the Canadian Registry of Venous Thromboembolic Complications (1997) (1)
- Low-Molecular-Weight Heparin in the Pediatric Population (2002) (1)
- CENTRAL VENOUS CATHETER RELATED THROMBOSIS (CVLT) IN CHILDREN: ANALYSIS OF THE CANADIAN REGISTRY OF VENOUS THROMBOEMBOLIC COMPLICATIONS.▴ 939 (1996) (1)
- The Evaluation of a Whole Blood Prothrombin Time Monitor in a Pediatric-Outpatient and Home Setting (2002) (1)
- THE POSTNATAL DEVELOPMENT OF THE COAGULATION SYSTEM IN THE PREMATURE INFANT (1987) (1)
- Reply to: Antiphospholipid antibody syndrome as a cause of venous thrombosis in childhood (1994) (1)
- Coagulation screening testsinhighrisk neonates: aprospective cohort study (1992) (0)
- #509 Central venous catheters (CVLs) in children: life saving devices with clinically important thromboembolic complications, including mortality (1997) (0)
- epithelium on thrombin generation on fetal distal lung Effect of a novel covalent antithrombin-heparin (2006) (0)
- Low-Molecular-Weight Heparin on Cancellous Bone in Rats A Histomorphometric Comparison of the Effects of Heparin and (2013) (0)
- 508 Infants and children with sinovenous thrombosis and arterial ischemic stroke have a high prevalence of coagulation abnormalities (1997) (0)
- ANTITHROMBOTIC PROPERTIES OF HEPARIN IN A NEONATAL MODEL OF THROMBIN INDUCED VENOUS STASIS THROMBOSIS (1987) (0)
- MONITORING PEDIATRIC ORAL ANTICOAGULANT PATIENTS AT HOME WITH PROTIME MICROCOAGULATION SYSTEM. 895 (1996) (0)
- In-Oxine Platelet Survivals in Thrombocytopenic Infants (2005) (0)
- A TRIPLE-BLIND PLACEBO-CONTROLLED RANDOMIZED TRIAL OF ANTITHROMBIN THERAPY IN NEONATAL RESPIRATORY DISTRESS SYNDROME † 1035 (1997) (0)
- UTILITY OF IMPEDANCE PLETHYSMOGRAPHY IN CHILDREN WITH CLINICALLY SUSPECTED VENOUS THROMBOEMBOLIC DISEASE (1987) (0)
- Influence of lung maturity on bronchoalveolar fibrin deposition and clearance in lung injury syndromes. (1994) (0)
- Abstract 2087: Factors Associated With Thrombotic Complications in the First 2 Years After the Fontan Procedure: A Multicentre Prospective Study (2009) (0)
- A Multicentre Randomized Trial Comparing Anticoagulation Versus Aspirin as Primary Thromboprophylaxis for Two Years After Fontan Procedure in Children (2009) (0)
- α2-MACROGLOBULIN IS A MORE IMPORTANT INHIBITOR OF THROMBIN IN INFANT PLASMA THAN IN ADULT PLASMA (1987) (0)
- 895 CLINICAL IMPACT OF NEONATAL THROMBOCYTOPENIA–A PROSPECTIVE ONE YEAR STUDY (1985) (0)
- 783 PRESENCE OF A SERINE PROTEASE IN UNACTIVATED PLASMA OF CHILDREN WITH COOLEY'S ANEMIA (1981) (0)
- Heparins proteins covalent conjugates containing an alpha-carbonyl-amine and methods for their production (1996) (0)
- ANTIPHOSPHOLIPID ANTIBODY SYNDROME AS A CAUSE OF VENOUS THROMBOSIS IN CHILDHOOD. AUTHORS' REPLY (1994) (0)
- Impairment of the Fibrinolytic System is Present and is a Marker for Endothelial Dysfunction in Adolescents after Kawasaki Disease (2003) (0)
- Boers AMM, Jansen IGH, Beenen LF, et al. Association of follow-up infarct volume with functional outcome in acute ischemic stroke: a pooled analysis of seven randomized trials. Journal of Neurointerventional Surgery (2018) (2018) (0)
- The Coagulation System in the Newborn In/ant 1.12 Anticoagulant and Thrombolytic Therapy in the Newborn (1991) (0)
- 782 POOR CLINICAL STATUS IMPAIRS THE POSTNATAL RISE OF THE CONTACT FACTORS IN PREMATURE INFANTS (1981) (0)
- Blood clots and strokes : a guide for parents and little folks (1998) (0)
- epithelium on thrombin generation on fetal distal lung Effect of a novel covalent antithrombin-heparin (2006) (0)
- Comprar Blood Clots and Strokes: A Guide for Parents and Little Folks | Maureen Andrew | 9781550090642 | Mcgraw-Hill Education (2008) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Maureen Andrew?
Maureen Andrew is affiliated with the following schools:
